A G Pandya Selected Research

Rituximab (Mabthera)

6/2016

Rituximab in the treatment of 38 patients with Pemphigus with long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A G Pandya Research Topics

Disease

3	Pemphigus (Pemphigus Vulgaris) 06/2016 - 07/2000
2	Melanosis (Freckles) 03/2018 - 03/2001
1	Vitiligo 01/2019
1	Burns 01/2018
1	Pyoderma Gangrenosum 06/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2009
1	Meibomitis 04/2003
1	Blepharitis 04/2003
1	Erythema 09/2001
1	Acne Vulgaris 09/2001
1	Pruritus (Itching) 09/2001
1	Infections 04/2000
1	Dermatitis 01/2000
1	Hyperpigmentation 01/2000

Drug/Important Bio-Agent (IBA)

2	SteroidsIBA 01/2019 - 03/2001
2	Etanercept (Enbrel)FDA Link 06/2012 - 04/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2001 - 03/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Tranexamic Acid (AMCA)FDA Link 03/2018
1	Rituximab (Mabthera)FDA Link 06/2016
1	Minocycline (Cyclops)FDA LinkGeneric 04/2003
1	LipidsIBA 04/2003
1	Nonesterified Fatty Acids (NEFA)IBA 04/2003
1	RetinoidsIBA 09/2001
1	Adapalene (Differin)FDA LinkGeneric 09/2001
1	hydroquinone (Esoterica)FDA Link 03/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2000
1	Pharmaceutical PreparationsIBA 01/2000

Therapy/Procedure

2	Phototherapy (Light Therapy) 01/2019 - 01/2018
1	Microspheres (Microsphere) 09/2001